Literature DB >> 23378427

Evidence for postinitiation regulation of mRNA biogenesis in tuberculosis.

Hugh Salamon1, Yaming Qiao, Jeff C Cheng, Ken D Yamaguchi, Patricia Soteropoulos, Michael Weiden, Maria Laura Gennaro, Richard Pine.   

Abstract

Mycobacterium tuberculosis infection alters macrophage gene expression and macrophage response to IFN-γ, a critical host defense cytokine. However, regulation of these changes is poorly understood. We report discordance of changes in nascent transcript and total nuclear RNA abundance for the transcription factors STAT1 and IRF1, together with lack of effect on their RNA half-lives, in human THP-1 cells infected with M. tuberculosis and stimulated with IFN-γ. The results indicate that negative postinitiation regulation of mRNA biogenesis limits the expression of these factors, which mediate host defense against M. tuberculosis through the cellular response to IFN-γ. Consistent with the results for STAT1 and IRF1, transcriptome analysis reveals downregulation of postinitiation mRNA biogenesis processes and pathways by infection, with and without IFN-γ stimulation. Clinical relevance for regulation of postinitiation mRNA biogenesis is demonstrated by studies of donor samples showing that postinitiation mRNA biogenesis pathways are repressed in latent tuberculosis infection compared with cured disease and in active tuberculosis compared with ongoing treatment or with latent tuberculosis. For active disease and latent infection donors from two populations (London, U.K., and The Gambia), each analyzed using a different platform, pathway-related gene expression differences were highly correlated, demonstrating substantial specificity in the effect. Collectively, the molecular and bioinformatic analyses point toward downregulation of postinitiation mRNA biogenesis pathways as a means by which M. tuberculosis infection limits expression of immunologically essential transcription factors. Thus, negative regulation of postinitiation mRNA biogenesis can constrain the macrophage response to infection and overall host defense against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23378427      PMCID: PMC3711638          DOI: 10.4049/jimmunol.1202185

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

Review 1.  Alternative polyadenylation: a twist on mRNA 3' end formation.

Authors:  Carol S Lutz
Journal:  ACS Chem Biol       Date:  2008-09-26       Impact factor: 5.100

2.  Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection.

Authors:  Scott A Shell; Candice Hesse; Sidney M Morris; Christine Milcarek
Journal:  J Biol Chem       Date:  2005-10-05       Impact factor: 5.157

3.  Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells.

Authors:  Yue Wang; Heather M Curry; Bruce S Zwilling; William P Lafuse
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

4.  Splicing of NOD2 (CARD15) RNA transcripts.

Authors:  Euphemia Leung; Jiwon Hong; Alan Fraser; Geoffrey W Krissansen
Journal:  Mol Immunol       Date:  2006-05-03       Impact factor: 4.407

5.  IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions.

Authors:  Ken D Yamaguchi; Daniel L Ruderman; Ed Croze; T Charis Wagner; Sharlene Velichko; Anthony T Reder; Hugh Salamon
Journal:  J Neuroimmunol       Date:  2008-02-14       Impact factor: 3.478

6.  Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis.

Authors:  Irena Jaresová; Daniela Rozková; Radek Spísek; Ales Janda; Jitka Brázová; Anna Sedivá
Journal:  Microbes Infect       Date:  2007-07-01       Impact factor: 2.700

7.  Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.

Authors:  Hye-Ryoun Kim; Seung Sik Hwang; Hyun Ji Kim; Sang Min Lee; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

Review 8.  Alternative splicing in the NF-kappaB signaling pathway.

Authors:  Joshua R Leeman; Thomas D Gilmore
Journal:  Gene       Date:  2008-07-22       Impact factor: 3.688

Review 9.  Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

Authors:  G Sotgiu; G Ferrara; A Matteelli; M D Richardson; R Centis; S Ruesch-Gerdes; O Toungoussova; J-P Zellweger; A Spanevello; D Cirillo; C Lange; G B Migliori
Journal:  Eur Respir J       Date:  2009-02-27       Impact factor: 16.671

10.  Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles.

Authors:  Nguyen Thuy Thuong Thuong; Sarah J Dunstan; Tran Thi Hong Chau; Vesteinn Thorsson; Cameron P Simmons; Nguyen Than Ha Quyen; Guy E Thwaites; Nguyen Thi Ngoc Lan; Martin Hibberd; Yik Y Teo; Mark Seielstad; Alan Aderem; Jeremy J Farrar; Thomas R Hawn
Journal:  PLoS Pathog       Date:  2008-12-05       Impact factor: 6.823

View more
  1 in total

1.  Cutting edge: Vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection.

Authors:  Hugh Salamon; Natalie Bruiners; Karim Lakehal; Lanbo Shi; Janani Ravi; Ken D Yamaguchi; Richard Pine; Maria Laura Gennaro
Journal:  J Immunol       Date:  2014-06-04       Impact factor: 5.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.